COVID-19 coagulopathy vs disseminated intravascular coagulation.

Levi, Marcel

Levi, Marcel.

Levi M; Department of Medicine, University College London Hospitals (UCLH) NHS Foundation Trust, London, United Kingdom; and Cardiometabolic Programme, Biomedical Research Centre, National Institute for Health Research, UCLH/University College London, London, United Kingdom.

Blood Adv ; 4(12): 2850, 2020 06 23.

Article in English | MEDLINE | ID: covidwho-612129

Subject(s)

Coronavirus Infections/blood; Disseminated Intravascular Coagulation/diagnosis; Pneumonia, Viral/blood; Thrombophilia/diagnosis; Betacoronavirus; COVID-19; Coronavirus Infections/complications; Coronavirus Infections/mortality; Diagnosis, Differential; Disseminated Intravascular Coagulation/blood; Endothelium, Vascular/physiopathology; Endothelium, Vascular/virology; Fibrin Fibrinogen Degradation Products/analysis; Humans; Pandemics; Pneumonia, Viral/complications; Pneumonia, Viral/mortality; Prothrombin Time; Pulmonary Embolism/etiology; Respiratory Distress Syndrome/blood; Respiratory Distress Syndrome/etiology; Respiratory Distress Syndrome/pathology; SARS-CoV-2; Thrombocytopenia/etiology; Thrombophilia/blood; Thrombophilia/etiology; Thrombotic Microangiopathies/blood; Thrombotic Microangiopathies/diagnosis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Thrombophilia / Disseminated Intravascular Coagulation Type of study: Diagnostic study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Blood Adv Year: 2020 Document Type: Article Affiliation country: Bloodadvances.2020002197

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google